Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Pharma
How Lundbeck’s CEO aims to keep firm ‘punching above its weight’
Lundbeck’s CEO, Charl van Zyl, told Fierce that he is confident the company can prove its mettle as a “neuroscience challenger.”
Fraiser Kansteiner
Aug 21, 2026 11:30am
Fierce Biotech
How India can build on its budding innovative R&D moment: report
Jul 23, 2026 5:00am
Alembic site hit with warning letter on patient consent concerns
Jul 21, 2026 11:40am
Verastem mulls options on approved asset in pancreatic cancer
Jun 17, 2026 3:00pm
The top 10 pharma R&D budgets of 2025
Apr 10, 2026 9:28am
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
